Suven Life Shares Surge 5% On Getting Patent For Drug

Mumbai, Mar 14 (PTI) Shares of Suven Life Sciences surged 5 per cent today as the company has been granted a patent each by China, Eurasia and Hong Kong for a drug used in the treatment of neuro-degenerative diseases.

The stock soared 5 per cent to Rs 211 on BSE. On NSE, shares of the company climbed 4.74 per cent to Rs 210.90.

Suven Life Shares Surge 5% On Getting Patent For Drug
Suven Life Sciences: Quotes, News
BSE 194.60BSE Quote2.9 (1.49%)
NSE 194.90NSE Quote2.8 (1.44%)

The company has been granted "one product patent from China, one product patent from Eurasia and one product patent from Hong Kong corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with neuro-degenerative diseases", it said in a BSE filing.

The patents will be valid till 2032. "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS (central nervous system) arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally," said Venkat Jasti, CEO Suven Life.


Read more about: suven life
Story first published: Monday, March 14, 2016, 13:35 [IST]
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?